Parkinson's disease can cause dementia, but it does not always

Some people with Parkinson's disease develop dementia as the condition progresses, while others do not. When dementia does occur alongside Parkinson's, it is called Parkinson's disease dementia (PDD). The risk increases the longer someone has Parkinson's disease — roughly one in four people with Parkinson's will develop dementia within 10 years of diagnosis, though this varies widely from person to person.

The dementia that develops with Parkinson's is different from Alzheimer's disease dementia. It typically affects thinking speed, attention, and the ability to plan or organize tasks before it affects memory. A person might struggle to follow a conversation or manage multiple steps in a task, even when they remember facts clearly.

Not everyone with Parkinson's will develop dementia. Some people have Parkinson's for decades without cognitive decline. Age at diagnosis, how quickly the disease progresses, and genetics all play a role in who develops dementia and when.

Key Takeaways

  • Parkinson's disease dementia develops in some but not all people with Parkinson's, usually after living with the disease for several years.
  • Parkinson's dementia typically affects thinking speed and attention before it affects memory, which is different from Alzheimer's dementia.
  • Older age at Parkinson's diagnosis and faster disease progression increase the risk of developing dementia.
  • A neurologist can test thinking and memory to detect early cognitive changes and distinguish Parkinson's dementia from other types.
  • Medications used for Parkinson's motor symptoms may need adjustment if dementia develops, because some can worsen confusion.

How Parkinson's disease damages the brain in ways that cause dementia

Parkinson's disease damages brain cells that produce dopamine, a chemical that controls movement. As the disease progresses, it also damages other brain regions and depletes other chemicals, including acetylcholine and serotonin, which are involved in thinking, memory, and mood.

In Parkinson's dementia, abnormal protein deposits called Lewy bodies accumulate in brain cells. These same deposits appear in a separate condition called Lewy body dementia, which shares some features with Parkinson's dementia but develops differently. The buildup of these proteins interferes with how brain cells communicate and eventually kills cells in regions responsible for attention, planning, and executive function — the mental processes that let you organize tasks and make decisions.

The brain damage in Parkinson's dementia is progressive, meaning it worsens over time. However, the rate of decline varies. Some people experience slow cognitive changes over many years, while others decline more quickly.

Early signs of cognitive changes in Parkinson's disease

Cognitive changes in Parkinson's often start subtly. A person might notice they take longer to think through problems, lose focus during conversations, or struggle to switch between tasks. They may repeat questions or forget recent conversations, though they remember older events clearly. Some people become more withdrawn or anxious as thinking becomes harder.

In the early stages, these changes might be dismissed as normal aging or stress. The key difference is that they represent a change from how that person used to function. A spouse or adult child often notices the shift before the person with Parkinson's does.

Other early signs include difficulty with complex tasks like managing finances or following written instructions, trouble finding words, or slowed thinking that makes conversations feel effortful. Some people experience visual hallucinations — seeing things that are not there — which can be an early sign of cognitive decline in Parkinson's.

Risk factors that make dementia more likely in Parkinson's disease

Age at diagnosis is one of the strongest predictors. People diagnosed with Parkinson's after age 70 are more likely to develop dementia than those diagnosed in their 50s or 60s. This may be because older brains are already experiencing age-related changes that combine with Parkinson's damage.

How quickly Parkinson's progresses also matters. People whose motor symptoms worsen rapidly — tremor, stiffness, and movement problems — tend to have faster cognitive decline as well. In contrast, people with slow motor progression often have slower cognitive changes or none at all.

Genetic factors play a role. Certain genetic mutations linked to Parkinson's carry higher dementia risk. A family history of dementia or Parkinson's may increase risk, though this is not absolute.

Severity of motor symptoms at diagnosis can predict cognitive risk. People with more severe movement problems at the start tend to have higher dementia risk later, though again this is not certain for any individual.

How doctors test for cognitive changes in Parkinson's disease

A neurologist or geriatrician can perform brief thinking tests during an office visit. Common tests include the Montreal Cognitive Assessment (MoCA), which takes about 10 minutes and checks attention, memory, language, and planning skills. Another is the Mini-Cog, which is even shorter and focuses on memory and drawing ability.

These office tests are screening tools, not definitive diagnoses. If results suggest cognitive decline, the doctor may refer for more detailed neuropsychological testing, which takes several hours and examines thinking in depth across many domains. This detailed testing can identify which specific thinking skills are affected and help rule out other causes like depression, medication side effects, or sleep problems that can mimic dementia.

Brain imaging such as MRI or PET scans can show patterns of brain damage consistent with Parkinson's dementia, though imaging alone cannot diagnose dementia. The diagnosis is made by combining test results, the person's history, and how symptoms have changed over time.

Medications and treatments when Parkinson's dementia develops

Some medications used to treat Parkinson's motor symptoms can worsen confusion or hallucinations if dementia develops. Anticholinergic drugs, which help with tremor and stiffness, are particularly likely to cause cognitive side effects. A neurologist may reduce or stop these medications if dementia appears, even if it means some return of movement problems.

Medications that boost acetylcholine, such as donepezil (Aricept) or rivastigmine (Exelon), may help slow cognitive decline in Parkinson's dementia. These are the same drugs used for Alzheimer's dementia. They do not stop the disease but may help maintain thinking skills longer. A doctor can discuss whether these are appropriate for an individual's situation.

Beyond medication, cognitive training, physical activity, and social engagement may help preserve thinking skills. Regular exercise, particularly aerobic activity, shows promise in slowing cognitive decline in Parkinson's. Occupational therapy can teach strategies for managing complex tasks as thinking becomes harder.

Difference between Parkinson's dementia and other types of dementia

Parkinson's dementia and Lewy body dementia both involve Lewy body protein deposits, but they develop in different order. In Parkinson's dementia, movement problems come first, and cognitive changes develop years later. In Lewy body dementia, cognitive changes and hallucinations appear first, with movement problems developing later or not at all.

Alzheimer's dementia typically affects memory earliest and most severely. A person with Alzheimer's might forget recent conversations or misplace objects frequently. In Parkinson's dementia, memory often stays relatively intact while thinking speed and attention decline. This difference can help doctors distinguish between them.

Vascular dementia, caused by small strokes in the brain, often develops suddenly or in steps rather than gradually. Parkinson's dementia progresses more steadily. These distinctions matter because treatment approaches differ, and knowing the type helps set realistic expectations for how the disease will progress.

What to ask a doctor about Parkinson's and dementia risk

If you or a family member has Parkinson's disease, these questions can help guide a conversation with a neurologist about dementia risk:

  • Based on my age and how my Parkinson's is progressing, what is my risk of developing dementia?
  • What early signs of cognitive change should I watch for, and who should I tell if I notice them?
  • How often should I have my thinking and memory tested?
  • Are any of my current Parkinson's medications likely to affect my thinking or cause confusion?
  • If cognitive changes do develop, what treatment options are available?
  • What can I do now — exercise, diet, cognitive activities — that might lower my dementia risk?

When to seek medical attention for cognitive concerns

Contact a neurologist if you notice a change in thinking, attention, or memory that represents a shift from baseline. This includes taking longer to process information, difficulty following conversations, trouble managing familiar tasks, or new confusion about time or place.

Seek urgent care if someone with Parkinson's suddenly becomes very confused, has severe hallucinations, or cannot care for themselves. This can signal a medical emergency such as infection, medication interaction, or acute brain changes that need when ready evaluation.

If a person with Parkinson's becomes withdrawn, loses interest in activities, or expresses hopelessness, contact their doctor promptly. Depression is common in Parkinson's and can worsen or mimic cognitive decline. It is treatable, and addressing it may improve thinking and mood.

Frequently Asked Questions

If I have Parkinson's disease, will I definitely get dementia?

No. Many people with Parkinson's disease never develop dementia, even after living with the condition for decades. Risk increases with age at diagnosis and how quickly the disease progresses, but individual outcomes vary widely. Your neurologist can discuss your personal risk based on your age, disease progression, and other factors.

How long after a Parkinson's diagnosis does dementia usually appear?

There is no set timeline. Some people develop cognitive changes within a few years of Parkinson's diagnosis, while others do not experience them for 10 or more years. Some never develop dementia at all. The rate depends on how quickly your Parkinson's progresses and other individual factors.

Can Parkinson's dementia be prevented?

There is no proven way to prevent Parkinson's dementia, but regular aerobic exercise, staying mentally and socially active, managing sleep problems, and treating depression may help slow cognitive decline. These steps support brain health generally and are worth doing regardless of dementia risk.

Is Parkinson's dementia the same as Alzheimer's disease?

No. They involve different brain changes and progress differently. Parkinson's dementia typically affects thinking speed and attention before memory, while Alzheimer's usually affects memory first. Treatment approaches differ, so knowing which type is important for planning care.

Can medication for Parkinson's motor symptoms cause the cognitive problems?

Some Parkinson's medications, particularly anticholinergic drugs, can worsen confusion or cause hallucinations, especially as someone ages. This is different from dementia caused by the disease itself. A neurologist can review medications and adjust them if cognitive side effects appear.